Evaluation of a Predictive Model of Individual Chance for Sustained Virological Response in Patients with Chronic Hepatitis C Treated with Peginterferon Alfa-2a and Ribavirin

被引：0
|
作者：
Mauss, Stefan
Hueppe, Dietrich
Zehnter, Elmar
Richter, Swantje
Tappe, Andre
Hermann, Eva
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A840 / A840
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF A PREDICTIVE MODEL OF INDIVIDUAL CHANCE FOR SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN
    Mauss, S.
    Hueppe, D.
    Zehnter, E.
    Richter, S.
    Tappe, A.
    Herrmann, E.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S233 - S233
  • [2] OPTIMIZING A PREDICTIVE MODEL OF INDIVIDUAL CHANCE FOR SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) FOR REAL LIFE SETTINGS
    Mauss, Stefan
    Hueppe, Dietrich
    Zehnter, Elmar
    Richter, Swantje
    Alshuth, Ulrich
    Wellmann, Egbert
    Herrmann, Eva
    HEPATOLOGY, 2009, 50 (04) : 728A - 729A
  • [3] Anemia Predicts Sustained Virological Response in Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C Treated with Peginterferon Alfa-2a and Ribavirin
    Reau N.S.
    Korner E.J.
    Han J.
    Jensen D.
    Current Hepatology Reports, 2015, 14 (1) : 53 - 59
  • [4] Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin
    Foster, Graham R.
    Fried, Michael W.
    Hadziyannis, Stephanos J.
    Messinger, Diethelm
    Freivogel, Klaus
    Weiland, Ola
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (02) : 247 - 255
  • [5] A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
    Swain, Mark G.
    Lai, Ming-Yang
    Shiffman, Mitchell L.
    Cooksley, W. Graham E.
    Zeuzem, Stefan
    Dieterich, Douglas T.
    Abergel, Armand
    Pessoa, Mario G.
    Lin, Amy
    Tietz, Andreas
    Connell, Edward V.
    Diago, Moises
    GASTROENTEROLOGY, 2010, 139 (05) : 1593 - 1601
  • [6] Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin
    Ferenci, P
    Fried, MW
    Shiffman, ML
    Smith, CI
    Marinos, G
    Gonçales, FL
    Häussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxì, A
    Chaneac, M
    Reddy, KR
    JOURNAL OF HEPATOLOGY, 2005, 43 (03) : 425 - 433
  • [7] Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin
    Snoeck, Eric
    Wade, Janet R.
    Duff, Frank
    Lamb, Matthew
    Jorga, Karin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 699 - 709
  • [8] Sustained virological response to treatment of chronic hepatitis C with peginterferon alfa and ribavirin
    da Rosa, Junior Andre
    Blatt, Carine Raquel
    Peres, Kaite Cristiane
    Storb, Bernd Heinrich
    Silva, Rochele
    Farias, Mareni Rocha
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 48 (02) : 193 - 201
  • [9] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [10] Long-lasting sustained virological response in chronic hepatitis C patients previously treated with 40 kDa peginterferon alfa-2a (PEGASYS®).
    Swain, M
    Heathcote, EJ
    Lai, MY
    Bain, V
    Feinman, V
    Sherman, M
    Kaita, KD
    Gane, E
    Peltekian, K
    Lindsay, K
    Hoffman, J
    Brunda, M
    HEPATOLOGY, 2001, 34 (04) : 330A - 330A
12345